Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
OncoMed Pharmaceuticals Inc
| Metric | OncoMed Pharmaceuticals Inc Healthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $8M |
| Net income (latest) | −$6M |
| Operating margin | −128.0% |
| Net margin | −71.0% |
| Return on equity | −11.6% |
| Return on assets | −8.6% |
| Return on capital (ROCE) | −19.2% |
| Debt / equity | 0.35× |
| Revenue growth (YoY) | 26.3% |
| Altman Z″ (distress) | -11.01 |
| Accruals / assets | 60.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.